SynBioBeta Speaker
Joshua Geilhufe
Rhiza Bio Cons.
Principal
Josh is an independent consultant specializing in commercial strategy for platform biotechnologies in agriculture, industrials, and climate. His work focuses on the critical gaps that come after synthetic biology breakthroughs and before customer adoption.
Josh’s work in agriculture has spanned discovery of novel pesticides, biocatalysis for existing molecules, and development of biofertilizers. He has led product development partnerships with multinational partners in his time at Zymergen and Ginkgo Bioworks. In his first commercial role, he built techno-economic models for microbial carbon capture that secured funding and validation partnerships with Shell Canada and the LaFarge division of Holcim Group. As a researcher at Codexis, he engineered temperature- and solvent-stable enzymes for carbon capture and for biofuels production.
Josh holds an MS in Chemistry from Stanford and an MBA from Georgetown University.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Joshua
This Year
•
-
Planetary Health
Rooted in Resilience: Speeding Up SynBio Plant Adaptation in a Rapidly Changing Climate
Climate volatility is reshaping the future of food, demanding plants that can withstand heat, drought, and disease. Synthetic biology offers powerful tools to accelerate adaptation—engineering plants with traits that once took decades to breed. This session explores how innovators are designing resilient plants, building platforms for rapid trait development, and forging collaborations across agtech, biotech, multinationals, and policy. Join us to hear how synbio is moving beyond the lab to the field, reshaping agriculture for resilience, and ensuring farmers worldwide can thrive in the face of climate uncertainty.
Purchase Pass
Featuring
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Joshua Armstrong
Corteva
IDD/BP Leader
Bruce Schnicker
Pivot Bio
VP, Product Dev
Sowing the seeds for Biology's future
Michael Ferrari
Moby
VP, Head of Research
Data/AI “world-models” researcher bridging synbio to real markets.
•
-
Planetary Health
Rooted in Resilience: Speeding Up SynBio Plant Adaptation in a Rapidly Changing Climate
Climate volatility is reshaping the future of food, demanding plants that can withstand heat, drought, and disease. Synthetic biology offers powerful tools to accelerate adaptation—engineering plants with traits that once took decades to breed. This session explores how innovators are designing resilient plants, building platforms for rapid trait development, and forging collaborations across agtech, biotech, multinationals, and policy. Join us to hear how synbio is moving beyond the lab to the field, reshaping agriculture for resilience, and ensuring farmers worldwide can thrive in the face of climate uncertainty.
Purchase Pass
Featuring
Joshua Geilhufe
Rhiza Bio Cons.
Principal
First-market strategist for synbio agriculture and fermentation.
Lyle Ralston
Bayer Crop Science
CE Platform Lead
Engineering Crops for global food security
Joshua Armstrong
Corteva
IDD/BP Leader
Bruce Schnicker
Pivot Bio
VP, Product Dev
Sowing the seeds for Biology's future
Michael Ferrari
Moby
VP, Head of Research
Data/AI “world-models” researcher bridging synbio to real markets.
•
-
Planetary Health
Breakout Session Brought to you by Bayer Crop Science
Purchase Pass
•
-
Planetary Health
Breakout Session Brought to you by Bayer Crop Science
Purchase Pass
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
